IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden · Delayed Price · Currency is SEK 0.3510
-0.0230 (-6.15%)
Apr 24, 2026, 5:19 PM CET
IDL Diagnostics AB Market Cap
IDL Diagnostics AB has a market cap or net worth of 80.86 million as of April 24, 2026. Its market cap has decreased by -28.22% in one year.
Market Cap
80.86M
Enterprise Value
57.52M
Revenue
53.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since May 25, 2011, IDL Diagnostics AB's market cap has increased from 16.78M to 80.86M, an increase of 381.93%. That is a compound annual growth rate of 11.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 80.86M | -0.57% |
| Dec 30, 2025 | 81.32M | -9.49% |
| Dec 30, 2024 | 89.84M | -10.76% |
| Dec 29, 2023 | 100.67M | -29.52% |
| Dec 30, 2022 | 142.82M | 31.17% |
| Dec 30, 2021 | 108.88M | -38.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 138.47B |
| Getinge AB | 52.84B |
| Sectra AB | 51.79B |
| Camurus AB | 33.49B |
| Biovica International AB | 96.91M |
| Magle Chemoswed Holding AB | 96.64M |
| Vivesto AB | 87.46M |
| AcouSort AB | 84.66M |